Outlook Therapeutics Inc 's Leverage Ratio

OTLK's quarterly Leverage Ratio and Total Liabilities, Equity growth

In I Quarter 2023 Outlook Therapeutics Inc had stockholder deficit.

Within Biotechnology & Pharmaceuticals industry Outlook Therapeutics Inc achieved the lowest Leverage Ratio in the first quarter 2023. While total ranking remained the same in the first quarter 2023 compared to the previous quarter at no. .

Explain Leverage Ratio?
Who are OTLK Customers?
What are OTLK´s Total Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Leverage Ratio ▼

None ▼

Leverage Ratio ▼

OTLK Leverage Ratio	(Dec 31 2023) I. Quarter	(Sep 30 2023) IV. Quarter	(Jun 30 2023) III. Quarter	(Mar 31 2023) II. Quarter	(Dec 31 2022) I. Quarter
Y / Y Equity Change	-	-	-	-70.84 %	-67.72 %
Y / Y Total Liabilities Change	-1.92 %	136.16 %	169.92 %	37.24 %	57.19 %
Leverage Ratio MRQ	-	-	-	4.15	2.98
OTLK's Total Ranking	#	#	#	#	#
Seq. Equity Change	-	-	-	-33.45 %	80.38 %
Seq. Total Liabilities Change	-1.52 %	-6.43 %	14.73 %	-7.23 %	137.12 %

New: More OTLK's historic Leverage Ratio results >>

Leverage Ratio first quarter 2023 Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	#
Healthcare Sector	#
Overall Market	#

Leverage Ratio Statistics
High	Average	Low
0	0	0

Financial Statements
Outlook Therapeutics Inc 's Equity	$ -24 Millions	Visit OTLK's Balance sheet
Outlook Therapeutics Inc 's Total Liabilities	$ 46 Millions	Visit OTLK's Balance sheet
Source of OTLK's Sales		Visit OTLK's Sales by Geography

Cumulative Outlook Therapeutics Inc 's Leverage Ratio

OTLK's Leverage Ratio for the trailling 12 Months

OTLK Leverage Ratio	(Dec 31 2023) I. Quarter	(Sep 30 2023) IV. Quarter	(Jun 30 2023) III. Quarter	(Mar 31 2023) II. Quarter	(Dec 31 2022) I. Quarter
Y / Y Equity TTM Growth	-	-	-	-70.84 %	-67.72 %
Y / Y Total Liabilities TTM Growth	-1.92 %	136.16 %	169.92 %	37.24 %	57.19 %
Leverage Ratio TTM	-	29.68	5.43	2.34	1.45
Total Ranking TTM
Seq. Equity TTM Growth	-	-	-	-33.45 %	80.38 %
Seq. Total Liabilities TTM Growth	-1.52 %	-6.43 %	14.73 %	-7.23 %	137.12 %

Leverage ratio ranking by company, industry and sector >> Back to OTLK Financial Strength Comparisons >> Compare OTLK Leverage Ratio to its Peers

On the trailing twelve months basis During the 12 months period ending I Quarter 2023 company had stockholder deficit.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry OTLK recorded the lowest Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Leverage Ratio?
Who are OTLK Customers?
What are OTLK´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within:	No.
Within the Biotechnology & Pharmaceuticals Industry	#
Healthcare Sector	#
Within the Market	#

trailing twelve months Leverage Ratio Statistics
High	Average	Low
0	0	0

Companies with similar Leverage Ratio in the quarter ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry

Leverage Ratio

Dec 31 2023 MRQ Total Liabilities

Dec 31 2023 MRQ Equity

Date modified: 2024-04-04T08:21:23+00:00

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com